Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: Pediatric FEcal Microbiota Transplant for Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial evaluating fecal microbiota transplantation for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: McMaster Children's Hospital | Conditions: Inflammatory Bowel Disease, Ulcerative Colitis | Phase 1 | Status: COMPLETED